MC1288A1 - N-(1-methyl 2-pyrrolidinyl methyl)2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives,leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire - Google Patents

N-(1-methyl 2-pyrrolidinyl methyl)2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives,leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire

Info

Publication number
MC1288A1
MC1288A1 MC791406A MC1406A MC1288A1 MC 1288 A1 MC1288 A1 MC 1288A1 MC 791406 A MC791406 A MC 791406A MC 1406 A MC1406 A MC 1406A MC 1288 A1 MC1288 A1 MC 1288A1
Authority
MC
Monaco
Prior art keywords
methyl
dimethoxy
derivatives
treatment
application
Prior art date
Application number
MC791406A
Other languages
English (en)
French (fr)
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of MC1288A1 publication Critical patent/MC1288A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC791406A 1978-10-11 1979-09-25 N-(1-methyl 2-pyrrolidinyl methyl)2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives,leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire MC1288A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7829005A FR2438650A1 (fr) 1978-10-11 1978-10-11 N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire

Publications (1)

Publication Number Publication Date
MC1288A1 true MC1288A1 (fr) 1980-07-22

Family

ID=9213607

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791406A MC1288A1 (fr) 1978-10-11 1979-09-25 N-(1-methyl 2-pyrrolidinyl methyl)2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives,leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire

Country Status (44)

Country Link
US (1) US4364867A (de)
JP (1) JPS5553268A (de)
AR (1) AR223186A1 (de)
AT (1) AT376203B (de)
AU (1) AU528827B2 (de)
BE (1) BE879139A (de)
BG (1) BG30926A3 (de)
CA (1) CA1133913A (de)
CH (1) CH641775A5 (de)
CS (1) CS221527B2 (de)
CY (1) CY1203A (de)
DD (1) DD146459A5 (de)
DE (1) DE2939914C2 (de)
DK (1) DK146157C (de)
EG (1) EG14181A (de)
ES (1) ES484814A0 (de)
FI (1) FI68220C (de)
FR (1) FR2438650A1 (de)
GB (1) GB2033900B (de)
GR (1) GR65219B (de)
HK (1) HK12384A (de)
HU (1) HU178113B (de)
IE (1) IE48957B1 (de)
IL (1) IL58379A (de)
IN (1) IN151482B (de)
IT (1) IT1162680B (de)
JO (1) JO1041B1 (de)
LU (1) LU81745A1 (de)
MA (1) MA18603A1 (de)
MC (1) MC1288A1 (de)
MX (1) MX6194E (de)
NL (1) NL7907307A (de)
NO (1) NO152971C (de)
NZ (1) NZ191699A (de)
OA (1) OA06351A (de)
PH (1) PH15431A (de)
PL (1) PL125527B1 (de)
PT (1) PT70277A (de)
RO (1) RO78157A (de)
SE (1) SE434835B (de)
SU (1) SU946401A3 (de)
YU (1) YU43460B (de)
ZA (1) ZA795375B (de)
ZM (1) ZM8179A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489327B1 (fr) * 1980-08-28 1984-05-18 Ile De France N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
JP3727538B2 (ja) 1998-08-03 2005-12-14 イー ホウィーラー,ロナルド 前立腺配合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (de) * 1966-01-21 1968-05-06
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
CH605793A5 (de) * 1974-03-05 1978-10-13 Ile De France
US4158060A (en) * 1974-12-18 1979-06-12 Synthelabo 2-Methoxy-benzamide derivatives
FR2358892A1 (fr) * 1976-07-19 1978-02-17 Ile De France N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Also Published As

Publication number Publication date
OA06351A (fr) 1981-06-30
NO793240L (no) 1980-04-14
AR223186A1 (es) 1981-07-31
DK146157B (da) 1983-07-11
CA1133913A (en) 1982-10-19
IE791903L (en) 1980-04-11
GB2033900B (en) 1982-09-15
MX6194E (es) 1984-12-13
JPS641470B2 (de) 1989-01-11
HU178113B (en) 1982-03-28
HK12384A (en) 1984-02-24
FR2438650B1 (de) 1981-08-14
BE879139A (fr) 1980-04-02
DK422879A (da) 1980-04-12
CY1203A (en) 1983-12-31
FI68220C (fi) 1985-08-12
AT376203B (de) 1984-10-25
FI68220B (fi) 1985-04-30
MA18603A1 (fr) 1980-07-01
ES8102093A1 (es) 1980-12-16
ZM8179A1 (en) 1980-07-21
IT7950444A0 (it) 1979-10-03
GR65219B (en) 1980-07-30
RO78157A (ro) 1982-02-01
ES484814A0 (es) 1980-12-16
DE2939914C2 (de) 1986-05-22
JO1041B1 (en) 1982-07-10
CS221527B2 (en) 1983-04-29
NZ191699A (en) 1981-11-19
NL7907307A (nl) 1980-04-15
IN151482B (de) 1983-04-30
SE7908227L (sv) 1980-04-12
PL125527B1 (en) 1983-05-31
SE434835B (sv) 1984-08-20
DD146459A5 (de) 1981-02-11
IL58379A0 (en) 1980-01-31
IE48957B1 (en) 1985-06-26
DE2939914A1 (de) 1980-04-30
PT70277A (fr) 1979-11-01
US4364867A (en) 1982-12-21
CH641775A5 (fr) 1984-03-15
FR2438650A1 (fr) 1980-05-09
NO152971C (no) 1985-12-27
EG14181A (en) 1984-09-30
FI793041A (fi) 1980-04-12
BG30926A3 (en) 1981-09-15
ZA795375B (en) 1980-10-29
DK146157C (da) 1983-12-05
NO152971B (no) 1985-09-16
AU528827B2 (en) 1983-05-12
IL58379A (en) 1983-03-31
YU43460B (en) 1989-08-31
SU946401A3 (ru) 1982-07-23
ATA639179A (de) 1984-03-15
IT1162680B (it) 1987-04-01
JPS5553268A (en) 1980-04-18
PL218673A1 (de) 1980-07-28
LU81745A1 (fr) 1980-05-07
PH15431A (en) 1983-01-18
AU5151979A (en) 1980-04-17
YU232279A (en) 1983-02-28
GB2033900A (en) 1980-05-29

Similar Documents

Publication Publication Date Title
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
PT64671A (fr) Dispositif pour la nettete et la desinfection des fosses nasales
NL930039I1 (nl) Derivaten van cis endo-2-azabicyclo-(3,3,0)-octaan-3-carbonzuur werkwijze voor de bereiding daarvan deze stoffen bevattende middelen en hun toepassing
BE864112A (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation
FR2315283A1 (fr) Procede et appareil d'oxygenation du sang
FR2531950B1 (fr) Derives d'amides d'acide o-amines, leur preparation, leur utilisation dans le traitement des affections du systeme nerveux central et des troubles cardiovasculaires, et compositions les contenant
FR2455572B1 (fr) Derives de phenylethylamine, leur preparation et utilisation dans le traitement des affections cardiovasculaires, et compositions les contenant
MC1288A1 (fr) N-(1-methyl 2-pyrrolidinyl methyl)2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives,leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
BE858356A (fr) Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique
BE870644A (fr) Appareil pour le traitement de feves et de graines analogues.
FR2320572A1 (fr) Procede et appareil de tirage d'epreuves
BE846460A (fr) Procedes et appareil pour le traitement de produits
BE865816A (fr) Derives d'acide benzoique, leur procede de preparation et leur application therapeutique.
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
RO71982A (ro) Procedeu de micsorare a continutului de substante lipidice si de acizi nucleici al unor mase celulare microbiene
FR2303462A1 (fr) Appareil pour planter des plantes et autres
JPS52101896A (en) Method and device for removing poison of liquid as blood* dialyzed liquid or the like
BE871860A (fr) Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation
FR2503149B1 (fr) Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
FR2503150B1 (fr) Mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
BE865891A (fr) Nouvelles compositions pharmaceutiques destine notamment au traitement des troubles fonctionnels cerebraux
PT69486A (fr) Procede de preparation d'esters benzylideniques et leur application en therapeutique
BE882635A (fr) Appareil d'hydrotherapie, en particulier pour le traitement des algies vertebrales

Legal Events

Date Code Title Description
YP Annual fee paid